In topotecan-resistant ovarian cancer cell lines, it is first observed that SAMD4 gene is overexpressed, and this is also the first report of SAMD4 gene in drug resistance of ovarian cancer cells [68, 69]. Here, SAMD4A is linked to ovarian carcinoma.